Featured,Spotlight Stock Health Canada Approves First Special Access Program Requests for Psilocybin By Dennis Mutua April 05, 2022 About two weeks ago, Dr. Valorie Masuda MD received approval from the Special Access Program (SAP) to treat six patients suffering from end-of-life distress with psilocybin and psychotherapy. In support of the SAP application, Psy...
Psychedelic Stocks Ketamine Clinics: Does a Physician’s Specialty Matter? By Dennis Mutua April 01, 2022 Ketamine clinics are run by various provider types in the United States. In some states, mid-level practitioners (e.g., Nurse Practitioners and Physician Assistants) can practice independently. In other states, such providers can ...
Psychedelic Stocks,Shroom News Silo Pharma Inks Agreement with Frontage Laboratories for Pharmacokinetic Study By Dennis Mutua April 01, 2022 Development stage biopharmaceutical company focusing on merging traditional therapies with psychedelic research Silo Pharma Inc. (OTCMKTS: SILO) has signed an agreement deal with Frontage Laboratories for Pharmacokinetic Study. ...
Featured,Shroom News Georgia Legislators Pass Bill to Form Psychedelic Study Committee By Dennis Mutua March 30, 2022 Lawmakers from Georgia have passed a bill advocating for the creation of a psychedelic study committee which will be dedicated in investigating the therapeutic potential of psychedelics like psilocybin, MDMA, DMT among others. The...
Spotlight Stock,Trends & Articles MindMed’s CFO David Guebert Set to Leave the Company This Week By Dennis Mutua March 29, 2022 David Guebert, the chief financial officer of Mindmed Inc. (NASDAQ: MNMD) (NEO: MMED) is set to retire from his position at the last day of this month i.e. March 31st. This announcement was made by the company’s director and chi...
Featured,Spotlight Stock Compass Pathways Enters Into Partnership to Launch Center for Mental Health Research and Innovation in the UK By Dennis Mutua March 28, 2022 Mental healthcare company focusing on accelerating patient access and experience to evidence-based innovation in mental health care COMPASS Pathways Plc. (NASDAQ: CMPS) has entered into a long-term strategic partnership to launch ...
Featured,Trends & Articles Third City in Michigan Decriminalizes Natural Psychedelics By Dennis Mutua March 25, 2022 On March 22, Hazel Park City Council, voted by a unanimous decision to decriminalize use of psilocybin mushrooms and other entheogenic plants across the city. Hazel Park becomes the third city in Michigan State to take such a move...
Psychedelic Stocks Open Psilocybin Sales in Vancouver, B.C. By Dennis Mutua March 24, 2022 Over the past few years, access to mushrooms containing psilocybin has become much easier in Vancouver, British Columbia, Canada. There are now four dispensaries that sell psilocybin mushrooms in the city, including two locations ...